IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut

Published Oct 08 2021 at 8:03 PM GMT
  • Shares of IsoPlexis, a company creating tools to zoom in on the flurry of protein activity surrounding a single cell, began trading on Friday.
  • The company aims to raise about $125 million with the IPO, which will be used to build the commercial team and advance the company's plans to play a bigger part in.



  • Published Oct 8, 2021 8:03 PM GMT